Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

The experimental renal cell carcinoma model in the chick embryo.

Fergelot P, Bernhard JC, Soulet F, Kilarski WW, Léon C, Courtois N, Deminière C, Herbert JM, Antczak P, Falciani F, Rioux-Leclercq N, Patard JJ, Ferrière JM, Ravaud A, Hagedorn M, Bikfalvi A.

Angiogenesis. 2013 Jan;16(1):181-94. doi: 10.1007/s10456-012-9311-z. Epub 2012 Oct 18.

PMID:
23076651
2.

Tetraidothyroacetic acid (tetrac) and tetrac nanoparticles inhibit growth of human renal cell carcinoma xenografts.

Yalcin M, Bharali DJ, Lansing L, Dyskin E, Mousa SS, Hercbergs A, Davis FB, Davis PJ, Mousa SA.

Anticancer Res. 2009 Oct;29(10):3825-31.

3.

Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.

Edeline J, Mottier S, Vigneau C, Jouan F, Perrin C, Zerrouki S, Fergelot P, Patard JJ, Rioux-Leclercq N.

Hum Pathol. 2012 Nov;43(11):1982-90. doi: 10.1016/j.humpath.2012.01.023. Epub 2012 May 22.

PMID:
22626276
4.

Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.

Maruschke M, Reuter D, Koczan D, Hakenberg OW, Thiesen HJ.

BJU Int. 2011 Jul;108(2 Pt 2):E29-35. doi: 10.1111/j.1464-410X.2010.09794.x. Epub 2011 Mar 16.

5.

Combined gene expression profiling and RNAi screening in clear cell renal cell carcinoma identify PLK1 and other therapeutic kinase targets.

Ding Y, Huang D, Zhang Z, Smith J, Petillo D, Looyenga BD, Feenstra K, Mackeigan JP, Furge KA, Teh BT.

Cancer Res. 2011 Aug 1;71(15):5225-34. doi: 10.1158/0008-5472.CAN-11-0076. Epub 2011 Jun 3.

6.

The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.

Grépin R, Guyot M, Giuliano S, Boncompagni M, Ambrosetti D, Chamorey E, Scoazec JY, Negrier S, Simonnet H, Pagès G.

Cancer Res. 2014 Feb 1;74(3):873-83. doi: 10.1158/0008-5472.CAN-13-1267. Epub 2013 Dec 12.

7.

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G.

Clin Cancer Res. 2005 Jul 15;11(14):5128-39.

8.

Expression of the PTTG1 oncogene is associated with aggressive clear cell renal cell carcinoma.

Wondergem B, Zhang Z, Huang D, Ong CK, Koeman J, Hof DV, Petillo D, Ooi A, Anema J, Lane B, Kahnoski RJ, Furge KA, Teh BT.

Cancer Res. 2012 Sep 1;72(17):4361-71. doi: 10.1158/0008-5472.CAN-11-2330. Epub 2012 Jul 17.

9.

[Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma].

Chang BD, Cao LS, Zhou HL.

Zhonghua Zhong Liu Za Zhi. 2009 Sep;31(9):687-90. Chinese.

PMID:
20021866
10.
11.

Pathway signature and cellular differentiation in clear cell renal cell carcinoma.

Tun HW, Marlow LA, von Roemeling CA, Cooper SJ, Kreinest P, Wu K, Luxon BA, Sinha M, Anastasiadis PZ, Copland JA.

PLoS One. 2010 May 18;5(5):e10696. doi: 10.1371/journal.pone.0010696.

12.
13.

An alternative in vivo system for testing angiogenic potential of human neuroblastoma cells.

Mangieri D, Nico B, Coluccia AM, Vacca A, Ponzoni M, Ribatti D.

Cancer Lett. 2009 May 18;277(2):199-204. doi: 10.1016/j.canlet.2008.12.014. Epub 2009 Jan 17.

PMID:
19150583
14.

CXCR7: a novel tumor endothelial marker in renal cell carcinoma.

Maishi N, Ohga N, Hida Y, Akiyama K, Kitayama K, Osawa T, Onodera Y, Shinohara N, Nonomura K, Shindoh M, Hida K.

Pathol Int. 2012 May;62(5):309-17. doi: 10.1111/j.1440-1827.2012.02792.x. Epub 2012 Feb 21.

PMID:
22524658
15.

Serous neoplasms of the pancreas share many, but not all aspects of their microvascular and angiogenic profile with low-grade clear cell renal cell carcinomas.

Liszka Ł, Pająk J, Gołka D.

Pathol Res Pract. 2014 Dec;210(12):901-8. doi: 10.1016/j.prp.2014.06.033. Epub 2014 Aug 1.

PMID:
25155377
16.

The chick embryo chorioallantoic membrane as a model for tumor biology.

Ribatti D.

Exp Cell Res. 2014 Nov 1;328(2):314-24. doi: 10.1016/j.yexcr.2014.06.010. Epub 2014 Jun 24. Review.

PMID:
24972385
17.

Variants in angiogenesis-related genes and the risk of clear cell renal cell carcinoma.

Qin C, Chen J, Li J, Ju X, Zhang S, Cao Q, Han Z, Li P, Shao P, Wang M, Zhang Z, Gu M, Zhang W, Yin C.

Mutagenesis. 2014 Nov;29(6):419-25. doi: 10.1093/mutage/geu046. Epub 2014 Sep 18.

PMID:
25239121
18.

Evaluation of metastatic and angiogenic potentials of human colon carcinoma cells in chick embryo model systems.

Subauste MC, Kupriyanova TA, Conn EM, Ardi VC, Quigley JP, Deryugina EI.

Clin Exp Metastasis. 2009;26(8):1033-47. doi: 10.1007/s10585-009-9293-4. Epub 2009 Oct 20.

19.

The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma.

Li M, Pathak RR, Lopez-Rivera E, Friedman SL, Aguirre-Ghiso JA, Sikora AG.

J Vis Exp. 2015 Oct 9;(104). doi: 10.3791/52411.

PMID:
26484588
20.

HAVCR/KIM-1 activates the IL-6/STAT-3 pathway in clear cell renal cell carcinoma and determines tumor progression and patient outcome.

Cuadros T, Trilla E, Sarró E, Vilà MR, Vilardell J, de Torres I, Salcedo M, López-Hellin J, Sánchez A, Ramón y Cajal S, Itarte E, Morote J, Meseguer A.

Cancer Res. 2014 Mar 1;74(5):1416-28. doi: 10.1158/0008-5472.CAN-13-1671. Epub 2014 Jan 3.

Supplemental Content

Support Center